TME Pharma (France) Market Value
| ALTME Stock | 0.15 0.00 0.00% |
| Symbol | TME |
TME Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TME Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TME Pharma.
| 12/08/2022 |
| 11/27/2024 |
If you would invest 0.00 in TME Pharma on December 8, 2022 and sell it all today you would earn a total of 0.00 from holding TME Pharma NV or generate 0.0% return on investment in TME Pharma over 720 days.
TME Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TME Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TME Pharma NV upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.39 | |||
| Information Ratio | 0.006 | |||
| Maximum Drawdown | 28.57 | |||
| Value At Risk | (7.14) | |||
| Potential Upside | 8.33 |
TME Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for TME Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TME Pharma's standard deviation. In reality, there are many statistical measures that can use TME Pharma historical prices to predict the future TME Pharma's volatility.| Risk Adjusted Performance | 0.0306 | |||
| Jensen Alpha | 0.3502 | |||
| Total Risk Alpha | (0.75) | |||
| Sortino Ratio | 0.0041 | |||
| Treynor Ratio | (0.1) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of TME Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
TME Pharma NV Backtested Returns
Currently, TME Pharma NV is out of control. TME Pharma NV owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0104, which indicates the firm had a 0.0104% return per unit of volatility over the last 3 months. We have found twenty-eight technical indicators for TME Pharma NV, which you can use to evaluate the volatility of the company. Please validate TME Pharma's coefficient of variation of 3493.82, and Risk Adjusted Performance of 0.0306 to confirm if the risk estimate we provide is consistent with the expected return of 0.0597%. The entity has a beta of -1.62, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning TME Pharma are expected to decrease by larger amounts. On the other hand, during market turmoil, TME Pharma is expected to outperform it. TME Pharma NV currently has a risk of 5.72%. Please validate TME Pharma potential upside, day median price, and the relationship between the sortino ratio and skewness , to decide if TME Pharma will be following its existing price patterns.
Auto-correlation | 0.22 |
Weak predictability
TME Pharma NV has weak predictability. Overlapping area represents the amount of predictability between TME Pharma time series from 8th of December 2022 to 3rd of December 2023 and 3rd of December 2023 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TME Pharma NV price movement. The serial correlation of 0.22 indicates that over 22.0% of current TME Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | -0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
TME Pharma NV lagged returns against current returns
Autocorrelation, which is TME Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting TME Pharma's stock expected returns. We can calculate the autocorrelation of TME Pharma returns to help us make a trade decision. For example, suppose you find that TME Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
TME Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If TME Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if TME Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in TME Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
TME Pharma Lagged Returns
When evaluating TME Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of TME Pharma stock have on its future price. TME Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, TME Pharma autocorrelation shows the relationship between TME Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in TME Pharma NV.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for TME Stock Analysis
When running TME Pharma's price analysis, check to measure TME Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TME Pharma is operating at the current time. Most of TME Pharma's value examination focuses on studying past and present price action to predict the probability of TME Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TME Pharma's price. Additionally, you may evaluate how the addition of TME Pharma to your portfolios can decrease your overall portfolio volatility.